Myeloma, or multiple myeloma, is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 and is characterized by the accumulation of ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Multiple myeloma is a rare, incurable, yet treatable, cancer that affects plasma cells. Thanks to recent developments, newer treatments targeting B cell maturation antigen (BCMA) became available ...

Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...

Multiple myeloma is a kind of blood cancer that starts in plasma cells. Inside most of your bones is a soft, spongy tissue called bone marrow. Here, your body makes hundreds of thousands of red ...

In 1980, Drs. Robert Kyle and Philip Greipp, Mayo Clinic hematologists, coined the term "smoldering multiple myeloma" to describe an accumulation of abnormal plasma cells in the bone marrow ...

Multiple myeloma can arise when plasma cells transform into malignant plasma cells which leads to the uncontrolled growth of these abnormal plasma cells.

Multiple myeloma (MM) is a form of blood cancer that begins in bone marrow cells called plasma cells. Abnormal plasma cells ...

Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all ...